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Staphylococcus aureus Colonization 
Modulates tic expression and the 
Host Immune Response in a Girl with 
tourette syndrome
Costantino Eftimiadi1,2* , Gemma Eftimiadi2 and Piergiuseppe Vinai2
1 Medicina Generale Convenzionata – ASL CN1, Carrù, Italy, 2 GNOSIS Research Group NPO, Magliano Alpi, Italy
A 9-year-old girl with Tourette syndrome (TS) and increased antibody levels against 
Streptococcus pyogenes was monitored longitudinally for the presence of nasopharyn-
geal bacteria, specific antibody titers, and autoimmunity directed against brain antigens. 
Microbiological monitoring indicated that the child was an intermittent Staphylococcus 
aureus nasopharyngeal carrier. Clinical improvements in motor tic frequency and severity 
were observed during the S. aureus colonization phase and were temporally correlated 
with the downregulation of anti-streptococcal and anti-D1/D2 dopamine receptor anti-
body production. After decolonization, clinical conditions reverted to the poor scores 
previously observed, suggesting a possible role of the immune response in bacterial 
clearance as a trigger of symptom recrudescence. These findings imply that a cause–
effect relationship exists between S. aureus colonization and tic improvement, as well 
as between bacterial decolonization and tic exacerbation. Understanding the impact of 
S. aureus on the host adaptive immune response and the function of autoantibodies in 
the pathogenesis of TS may alter approaches for managing autoimmune neuropsychi-
atric and tic disorders.
Keywords: Staphylococcus aureus, Streptococcus pyogenes, tourette syndrome, dopamine receptor 
autoantibodies, aso, paNDas, nasal carriage
INtRoDUCtIoN
Children with Tourette syndrome (TS) might be more prone to group A streptococcal (GAS) infec-
tions and could develop higher antibody titers against the pathogen than healthy controls (1). This 
signifies the existence of an underlying immunological disorder (2, 3). However, GAS infections are 
unlikely to exert a major effect on the severity of neuropsychiatric symptoms years after symptom 
onset (1). Nevertheless, other studies support a role of GAS infections and basal ganglia autoim-
munity in a subgroup of patients with TS and suggest a similarity between patients with Sydenham’s 
chorea and some patients with either TS (4) or chronic recurrent episodic acute exacerbations of 
Abbreviations: ASO, anti-streptolysin O; ASTA, anti-staphylolysin antibody; BBB, blood–brain barrier; CaM kinase II, calcium/
calmodulin-dependent protein kinase type II; DNase B, deoxyribonuclease B; ELISA, enzyme-linked immunosorbent assay; 
ESR, erythrocyte sedimentation rate; GAS, group A streptococcal; MS, multiple sclerosis; PANDAS, pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infection; PANS, pediatric acute-onset neuropsychiatric syndromes; 
OCD, obsessive–compulsive disorder; Th17 cell, T helper 17 cell; WBC, white blood cell; YGTSS, Yale global tic severity scale.
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tic and obsessive–compulsive indications (5), according to the 
pathogenesis of pediatric autoimmune neuropsychiatric disor-
ders associated with streptococcal infection (PANDAS) described 
by Swedo (6). Sydenham’s chorea was the first neuropsychiatric 
condition in which antibodies produced in response to GAS 
infections were found to cross-react with extracellular and intra-
cellular targets in the basal ganglia, resulting in a disease state 
(7–9). Despite this finding, no conclusive data are available (10, 
11), and the hypothesis that PANDAS and TS could be secondary 
to pathogenic autoantibodies is controversial (12, 13). Moreover, 
a consensus regarding the possible contribution of GAS infec-
tions to the etiology of tic disorders, especially TS, does not exist. 
Additionally, other pathogens can also induce postinfectious 
Tourette-like syndromes, including Mycoplasma pneumonia (14), 
Borrelia burgdorferi (15), and assorted viruses (16–18).
Case DesCRIptIoN
This study longitudinally investigated the possible associations 
between bacterial pathogens in nasopharyngeal and tonsil swabs, 
serological immune responses, and tic severity in an adolescent 
girl with TS, who first came to our attention in June 2012, when 
she was 9 years old. The patient exhibited a strong recrudescence 
of motor tics in the presence of high titers of anti-streptolysin O 
(ASO) antibodies (472 IU/mL; positive = >200 IU/mL).
A historical record released by the children’s neuropsychiatric 
public department of Azienda Sanitaria Locale Cuneo 1 (ASL 
CN1) indicated that the tic disorders began when the patient was 
7 years old. Learning disabilities at school, borderline intellectual 
functioning, and phobic anxiety disorder were also present at that 
time. Routine laboratory analyses were normal, and there was no 
record of any previous GAS infection.
Informed parental consent was obtained to enroll the child 
in a clinical and laboratory survey, according to the principles 
outlined in the Declaration of Helsinki (1964). The aims of this 
study, negligible risks associated with the investigation, and 
the prospective benefits to the community for better scientific 
knowledge of the pathogenesis of TS and other tic disorders 
were discussed in detail. The protocol included physical 
examinations, interviews, completion of questionnaires, and 
periodic drawings of small amounts of blood to measure ASO, 
anti-streptococcal deoxyribonuclease B (DNase B), and anti-
staphylolysin antibody (ASTA) titers, as well as white blood cell 
(WBC) counts and the erythrocyte sedimentation rate (ESR). 
Duplicate throat and nasal swabs were obtained for the micro-
biological assays and were analyzed on the same day by two 
different laboratories: the Centro Diagnostico Cernaia (Cuneo, 
Italy) and the Microbiology Department of ASL CN1 (Mondovì, 
Cuneo, Italy). An analysis for autoimmunity against brain 
antigens was conducted three times during the final 18 months 
of the study by the Wieslab AB Medical Laboratory (Malmo, 
Sweden), utilizing a test panel (Cunningham Panel) originally 
developed by Moleculera Labs (Oklahoma City, OK, USA). 
The assay comprised measurements of antibody titers against 
dopamine D1 and D2 receptors, lysoganglioside-GM1, and 
beta-tubulin, in addition to antibodies that induce the activation 
of calcium/calmodulin-dependent protein kinase type II (CaM 
kinase II) by binding to receptors on neural cell lines (7–9). Tic 
severity was monitored according to the Yale global tic severity 
scale (YGTSS; subscale 0–50).
During her first visit in June 2012, the patient’s tic sever-
ity score was 25, essentially indicating the presence of motor 
tics alone, and her ASO titer was elevated (472  IU/mL; posi-
tive = >200 IU/mL). Her ASO titers remained high (between 
350 and 400  IU/mL) for almost 3  years. Additionally, her 
anti-DNase B titers were always in the upper range (between 
360 and 340  IU/mL; positive = >200  IU/mL). The results of 
enzyme-linked immunosorbent assay (ELISA) analyses for 
ongoing autoimmunity against brain antigens are shown in 
Table 1. Four autoimmunity tests out of a panel of five were sig-
nificantly positive based on the reference values of the test panel 
manufacturer (Moleculera Labs) (Table 1, observation period 
A: before Staphylococcus aureus colonization). Meanwhile, 
ELISA tests for antinuclear antibodies were negative throughout 
the study (data not shown).
Combined pharmacological treatment with pimozide (4 mg/
day) and sertraline, a selective serotonin reuptake inhibitor (50 mg/
day), effectively controlled eye, head and shoulder movements, 
and comorbidities, both in frequency and severity. However, the 
complete elimination of trunk and abdominal movements, with 
tensing of the abdomen and urinary incontinence, was only slowly 
achieved. The patient’s clinical situation remained stable over the 
following 2  years, permitting a reduction in the daily doses of 
pimozide and sertraline to 1 and 25 mg/day, respectively. In late 
2014, an unusual improvement in motor tics was initially recorded 
by the family. Subsequent laboratory tests showed a significant 
decrease in the ASO titer to normal levels, along with a decrease in 
the anti-DNase B titer to reference values (i.e., below 200 IU/mL) 
(Figure 1). Moreover, antibody titers against dopamine D1 and 
D2 receptors yielded negative values (Table 1, observation period 
B: after S. aureus colonization) in the absence of any antibiotic 
treatment. Microbiological analyses of nasal and throat swabs 
revealed, for the first time since beginning the survey, the pres-
ence of S. aureus. Antibiotic susceptibility testing indicated that 
this bacterial strain was sensitive to 11 antibiotics out of a panel of 
12, with the only resistance being to benzylpenicillin. The patient’s 
YGTSS score dropped to seven, the lowest value recorded. Starting 
in November 2014, a clinical and laboratory survey was scheduled 
every 3 months, as well as once-monthly microbiological assays for 
the patient’s S. aureus carrier state.
A few months later, the scenario was completely reversed 
(Figure 1). S. aureus was no longer detected, and tic frequency 
and intensity rapidly returned to their previous poor scores with 
a combined symptomatology of motor and vocal tics. Parallel 
blood tests indicated a slight increase in WBC count (Table 1, 
observation period B), an ASO titer that increased from 47 to 
264 IU/mL (Figure 1), an increase in the ESR (Figure 1), and a 
significantly positive ASTA antibody titer (Table 1, observation 
period B). These data indicate a shift from an anti-inflammatory 
state (colonization) to a pro-inflammatory condition, coincident 
with staphylococcal clearance by the host. The staphylococcal 
colonization was indeed temporary, or rather recurrent, a situ-
ation historically occurring in ~30% of the normal population 
(19). Four months later, a S. aureus strain with the same pattern of 
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antibiotic susceptibility as that described above (and possibly the 
same strain) was again recovered from nostril and tonsil swabs; 
a significant clinical improvement was also observed (Figure 1). 
The clinical improvement was in fact so impressive that all 
pharmacological treatments were suspended. Autoantibodies 
against dopamine receptors were negative (Table 1, observation 
period C: during S. aureus colonization), as noted after the first 
colonization phase (Table  1, observation period B). However, 
anti-streptococcal antibody titers failed to decrease as rapidly as 
during the first colonization phase. Two months later, close to 
the end of the second colonization phase, vocal tic frequency and 
severity (grunts) increased to values never recorded before, with 
only a slight increase in motor tics (Figure 1). Microbiological 
analysis for the presence of GAS infections in pharyngo–tonsillar 
and nasal swabs was always negative.
BaCKGRoUND
To our knowledge, this is the first investigation of the role of 
S. aureus nasal carriage in a patient with a tic disorder. S. aureus 
is a bacterial pathogen equipped with a tremendous variety 
of virulence factors (20), and its phagocytosis by neutrophils 
requires a much higher expenditure of energy than that required 
for saprophytic strains (21). S. aureus is permanently present in 
about 20% of the general population, while ~30% transiently carry 
the pathogen and ~50% are not carriers (19). Nevertheless, host 
immunological response patterns indicate only two categories: 
carriers and non-carriers (19).
The nostril affords the main ecological niche where S. aureus 
resides in human beings, but the determinants of carrier state are 
not fully understood. Different hosts (22) and bacterial virulence 
factors (23–27) contribute to staphylococcal colonization and 
FIGURe 1 | Clinical and laboratory records. Arrows indicate the times of 
blood sampling for autoimmunity testing. ASO, anti-streptolysin O antibody 
(filled circles); anti-DNase B, anti-deoxyribonuclease B antibody (open 
circles); ESR, erythrocyte sedimentation rate (filled triangles); YGTSS motor, 
Yale global tic severity score motor subscale (filled squares); YGTSS vocal, 
Yale global tic severity score vocal subscale (open squares).
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could potentially influence the immunological response and the 
carrier status. Competition for the same biological niche and/or 
direct antagonistic effects by different bacterial species might in 
principle interfere with S. aureus colonization, as experiments 
with Staphylococcus epidermidis have demonstrated (28, 29). 
Existing models suggest that S. aureus colonization modulates 
host immune responses, inducing tolerance and suppression of 
pro-inflammatory reactions (22). Increased production of inter-
leukin (IL)-10 by monocyte-derived macrophages of the nasal 
submucosa (30), as well as bacterial superantigen induction of 
regulatory T cells (Tregs), is reportedly involved in these anti-
inflammatory and immune-modulatory strategies (31). Tregs, 
characterized by the expression of the forkhead transcription 
factor, FOXP3, and the IL-2 receptor α-chain, CD25, are essential 
for the prevention of both autoimmunity and excessive inflam-
matory responses to infection and might also facilitate bacterial 
colonization processes.
The immunological mechanisms involved in bacterial 
decolonization are better defined, at least in animal models. 
Current data indicate that a T helper 17 (Th17) cell-mediated 
inflammatory response is the key factor responsible for clearing 
of S. aureus from the nostrils (32). Ultimately, the colonization 
phase appears to trigger an anti-inflammatory response, whereas 
the decolonization phase triggers a pro-inflammatory response.
DIsCUssIoN
The temporal correlation observed herein between bacterial colo-
nization/tic improvement and decolonization/exacerbation was 
indeed surprising. These findings open interesting new questions 
regarding the possible biological mechanism(s), and particularly 
the immunological events, behind both phenomena. During the 
colonization phase first reported in 2014, anti-streptococcal anti-
body titers as well as autoantibodies against dopamine receptors 
D1 and D2 were downregulated and dropped to normal values; 
the concomitant clinical improvement in motor tic frequency 
and severity was impressive. During the second colonization 
phase in 2015, motor tic clinical improvement was also sig-
nificant and was accompanied by negative autoantibody titers 
against dopamine receptors and a decrease in anti-streptococcal 
antibody levels, albeit to a lower extent and with slower kinetics 
than in the first colonization phase. However, vocal tics were 
not controlled, because the worst YGTSS score was recorded 
while S. aureus was still present (Figure 1). The reason for the 
discrepancies is unclear, but we hypothesize that different brain 
targets with different pathogenetic mechanisms might have 
accounted for the two tic categories. Moreover, we do not have 
evidence of any relevant change in the patient lifestyle or of any 
environmental factor other than infections that could account 
for the tic severity fluctuations observed.
Whatever the mechanism, the clinical improvement in motor 
tic severity was temporally correlated with the staphylococcal 
colonization phases, and possibly also with the decreased anti-
dopamine receptor autoantibody levels. These findings are simi-
lar to those reported in post-streptococcal Sydenham’s chorea 
patients, where dopamine D1 and D2 receptor autoantibody lev-
els correlated with symptom severity (33). Our data also support 
an etiological role for GAS infections in the onset of tics, at least 
in a subgroup of patients with TS. Our observations, likewise, 
support the involvement of autoantibodies against dopamine 
receptors in the pathogenesis of some movement disorders.
This case could not be included in the group of PANDAS 
because there was neither an evidence for abrupt disease onset, 
which is required by the inclusion criteria (6), nor a symptom 
association with GAS isolation (6). In fact, the serological indica-
tion of a possible GAS infection could not be confirmed in the 
current investigation by streptococcal isolation, and the results 
of microbiological tests for Streptococcus pyogenes presence in 
nasal, throat, and tonsils swabs were always negative. Analyses 
performed on the parents of the patient revealed a similar intrigu-
ing response in the mother: above-normal ASO titers during the 
18 months of the 2014–2015 survey, ranging from 222 to 286 IU/
mL, with negative swab tests for GAS infection. This reinforces 
the hypothesis of an underlying genetic immunological imbal-
ance in the daughter (2, 3).
However, Swidsinski and colleagues reported that “various 
environmental conditions can shield bacteria, rendering them 
inaccessible for microbial diagnosis through a swab test” (34). 
We cannot, therefore, exclude in principle a hidden, subclinical, 
and localized GAS infection that was responsible for maintaining 
increased anti-streptococcal antibody production.
The lack of an abrupt, dramatic onset of an obsessive– 
compulsive disorder (OCD), or of a severely restricted food 
intake, exclude likewise the inclusion of this case in the “broader” 
category of the pediatric acute-onset neuropsychiatric syndromes 
(PANS), which include different infectious and non-infectious 
triggers (35). The case reported herein can be classified in our 
opinion as a subgroup of TS patients (rare?), where infectious 
agents could modulate the course of the illness. TS is on the 
contrary not uncommon (36), being a disorder occurring in up 
to 1% of children (37–39).
A discrepancy was observed between the decrease of antibody 
titers against dopamine D1 and D2 receptors and ASO occurring 
in the colonization phase and the increase of the inflammatory 
markers during bacterial clearance. The notion presented is 
that S. aureus colonization could trigger an anti-inflammatory 
modulatory response, whereas the decolonization process may 
trigger the opposite. An inflammatory rebound response was in 
fact fairly evident after bacterial clearance (Table 1, period B), 
given that the ESR, ASTA titer, and WBC counts were all above 
normal levels during this period compared to the levels occur-
ring before (Table  1, period A) and during the colonization 
phase (Table 1, period C). Furthermore, CaM kinase II values 
remained high throughout the entire observation period, sug-
gesting that the “main switch” of the illness was continuously 
“on,” even during the quiescent state when autoantibodies 
against dopamine receptors fell to negative values. The rapid 
reversal of clinical parameters following the clearance of S. 
aureus by the host supports a direct relationship between the 
decolonization process, the inflammatory response, and tic 
exacerbation. Transient microinvasions by S. aureus could be 
responsible for the immunological host response, according to 
the existing models of S. aureus nasal carriage (22) and to the 
increased ASTA titers observed.
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Moreover, the shift from an anti-inflammatory modulatory 
response to a pro-inflammatory state during the clearing process 
is consistent with the data from animal models showing that a 
pro-inflammatory, Th17 cell-associated immune response is 
required for S. aureus nasal decolonization, where the S. aureus 
nasal carriage clearance is T cell-dependent and mediated by 
IL-17A expression and neutrophil influx (32).
Interestingly, human Th17 lymphocytes promote blood–brain 
barrier (BBB) disruption and central nervous system inflam-
mation during the pathogenesis of multiple sclerosis (MS) (40), 
another neurological disease in which autoimmunity plays a 
central role. BBB leakage might be an important step to investi-
gate the pathogenesis of any autoimmune neurological disorder. 
Also in MS, S. aureus is considered a possible risk factor for the 
clinical exacerbation (41). Future studies on infection-driven 
immune-inflammatory mechanisms, potentially involved in the 
pathogenesis of tic disorders, should focus on bacterial virulence 
factors and immunological host responses that could locally 
affect BBB permeability allowing autoantibodies to reach their 
potential brain targets.
CoNCLUDING ReMaRKs
This case is the first demonstration of the modulation of tic 
manifestation in a S. aureus intermittent carrier with TS, during 
periodically occurring colonization and decolonization phases. 
A shift occurred from an anti-inflammatory modulatory response 
during the colonization phase to a pro-inflammatory state dur-
ing the clearing process. Thus, S. aureus nasal carriage possibly 
provides a new human model for the in vivo study of the interplay 
between infections, immunity, autoimmunity, and tic disorders.
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